These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 18482211

  • 1. Can pediatric steroid-free renal transplantation improve growth and metabolic complications?
    Bhakta N, Marik J, Malekzadeh M, Gjertson D, Ettenger R.
    Pediatr Transplant; 2008 Dec; 12(8):854-61. PubMed ID: 18482211
    [Abstract] [Full Text] [Related]

  • 2. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O.
    Transplantation; 2003 Nov 15; 76(9):1331-9. PubMed ID: 14627912
    [Abstract] [Full Text] [Related]

  • 3. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.
    Sarwal MM, Yorgin PD, Alexander S, Millan MT, Belson A, Belanger N, Granucci L, Major C, Costaglio C, Sanchez J, Orlandi P, Salvatierra O.
    Transplantation; 2001 Jul 15; 72(1):13-21. PubMed ID: 11468528
    [Abstract] [Full Text] [Related]

  • 4. Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients.
    Silverstein DM, Aviles DH, LeBlanc PM, Jung FF, Vehaskari VM.
    Pediatr Transplant; 2005 Oct 15; 9(5):589-97. PubMed ID: 16176415
    [Abstract] [Full Text] [Related]

  • 5. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.
    Nematalla AH, Bakr MA, Gheith OA, Elagroudy AE, Elshahawy el-M, Aghoneim M.
    Exp Clin Transplant; 2007 Dec 15; 5(2):673-9. PubMed ID: 18194120
    [Abstract] [Full Text] [Related]

  • 6. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J, John E, Lumpaopong A, Testa G, Sankary HN, Briars L, Kraft KA, Knight PS, Verghese P, Benedetti E.
    Pediatr Transplant; 2005 Aug 15; 9(4):456-63. PubMed ID: 16048597
    [Abstract] [Full Text] [Related]

  • 7. Single-center experience in pediatric renal transplantation using thymoglobulin induction and steroid minimization.
    Warejko JK, Hmiel SP.
    Pediatr Transplant; 2014 Dec 15; 18(8):816-21. PubMed ID: 25311592
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
    Ciancio G, Burke GW, Gaynor JJ, Roth D, Sageshima J, Kupin W, Tueros L, Hanson L, Rosen A, Ruiz P, Miller J.
    Transplantation; 2008 Jul 15; 86(1):67-74. PubMed ID: 18622280
    [Abstract] [Full Text] [Related]

  • 9. Potential influence of tacrolimus and steroid avoidance on early graft function in pediatric renal transplantation.
    Li L, Weintraub L, Concepcion W, Martin JP, Miller K, Salvatierra O, Sarwal MM.
    Pediatr Transplant; 2008 Sep 15; 12(6):701-7. PubMed ID: 18179640
    [Abstract] [Full Text] [Related]

  • 10. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
    Hamiwka LA, Burns A, Bell L.
    Pediatr Transplant; 2006 May 15; 10(3):337-44. PubMed ID: 16677358
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression.
    Satterwhite T, Chua MS, Hsieh SC, Chang S, Scandling J, Salvatierra O, Sarwal MM.
    Pediatr Transplant; 2003 Feb 15; 7(1):53-8. PubMed ID: 12581329
    [Abstract] [Full Text] [Related]

  • 12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 13. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.
    Clin Transplant; 2007 Nov 15; 21(1):101-9. PubMed ID: 17302598
    [Abstract] [Full Text] [Related]

  • 14. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.
    Abou-Ayache R, Büchler M, Lepogamp P, Westeel PF, Le Meur Y, Etienne I, Lobbedez T, Toupance O, Caillard S, Goujon JM, Bergougnoux L, Touchard G.
    Nephrol Dial Transplant; 2008 Jun 15; 23(6):2024-32. PubMed ID: 18199693
    [Abstract] [Full Text] [Related]

  • 15. [Daclizumab in combination with mycophenolate mofetil and a late introduction of Tacrolimus at low doses, as a therapeutic approach in the elderly renal transplant donor-recipients pairs in kidney transplant].
    Gentil MA, Osuna A, Capdevilla L, Cantarell C, Pereira P, Mazuecos A, González Molina M.
    Nefrologia; 2008 Jun 15; 28(3):287-92. PubMed ID: 18590495
    [Abstract] [Full Text] [Related]

  • 16. Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantation.
    Fangmann J, Arns W, Marti HP, Hauss J, Ketteler M, Beckurts T, Boesmueller C, Pohanka E, Martin PY, Gerhardt M, Farese S, Neumayer HH, Floege J, Gurr C, Budde K, DACH Study Group.
    Nephrol Dial Transplant; 2010 Jan 15; 25(1):283-92. PubMed ID: 19773417
    [Abstract] [Full Text] [Related]

  • 17. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G, Murer L, Ghio L, Pietrobon B, Ginevri F, Ferraresso M, Cardillo M, Scalamogna M, Perfumo F, Edefonti A, Zanon GF, Zacchello G.
    Transpl Int; 2005 Jan 15; 18(1):36-42. PubMed ID: 15612981
    [Abstract] [Full Text] [Related]

  • 18. Cost-benefit of steroid avoidance in renal transplant patients: a prospective randomized study.
    Gheith OA, Nematalla AH, Bakr MA, Refaie A, Shokeir AA, Ghoneim MA.
    Scand J Urol Nephrol; 2010 Apr 15; 44(3):175-82. PubMed ID: 20230185
    [Abstract] [Full Text] [Related]

  • 19. Long-term experience of steroid-free pediatric renal transplantation: effects on graft function, body mass index, and longitudinal growth.
    Wittenhagen P, Thiesson HC, Baudier F, Pedersen EB, Neland M.
    Pediatr Transplant; 2014 Feb 15; 18(1):35-41. PubMed ID: 24384046
    [Abstract] [Full Text] [Related]

  • 20. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.
    Pascual J, van Hooff JP, Salmela K, Lang P, Rigotti P, Budde K.
    Transplantation; 2006 Jul 15; 82(1):55-61. PubMed ID: 16861942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.